Article Content

Abstract

Background

In recent years, with the increasing challenges in living conditions, there has been a rise in individuals seeking psychiatric support. This situation may lead to changes in attitudes and perceptions towards psychiatric medication treatments.

Aim

This study aims to examine the attitudes of stable psychiatric patients, healthcare professionals, and the general population toward psychiatric medication treatments.

Method

The study included 311 stable psychiatric patients, 200 healthcare professionals, and 274 participants from the general population. Participants were administered a data form that questioned sociodemographic and clinical characteristics, the Drug Attitude Inventory-10, and the Beliefs about Medicines Questionnaire.

Results

The study reveals significant differences in attitudes towards medication among stable psychiatric patients, non-psychiatric healthcare professionals, and the general population. Stable psychiatric patients tend to have a stronger belief in the positive effects of medication and are more likely to internalize medications in their daily lives. However, this group experiences side effects more intensely compared to other groups. Healthcare professionals maintain a balanced stance regarding the benefits and side effects of medications, while the general population exhibits a more negative attitude towards medications and expresses greater concern about the addictive potential of these drugs.

Conclusion

Considering these differences may contribute to more effective management of treatment processes and improve attitudes toward medications.

Explore related subjects

Discover the latest articles and news from researchers in related subjects, suggested using machine learning.

  • Attitudes
  • Behavioral Medicine
  • Positive Psychology
  • Psychiatric Disorder
  • Psychopharmacology
  • Psychiatry

Data availability

No datasets were generated or analysed during the current study.

References

  1. De Las Cuevas C, Sanz EJ (2007) Attitudes toward psychiatric drug treatment: the experience of being treated. Eur J Clin Pharmacol 63(11):1063–1067. https://doi.org/10.1007/s00228-007-0358-5

    Article CAS Google Scholar

  2. Triandis HC (1971) Attitude and attitude change, vol 8. Wiley, New York

    Google Scholar

  3. Benkert O, Graf-Morgenstern M, Hillert A, Sandmann J, Ehmig SC, Weissbecker H, Kepplinger HM, Sobota K (1997) Public opinion on psychotropic drugs: an analysis of the factors influencing acceptance or rejection. J Nerv Ment Dis 185(3):151–158. https://doi.org/10.1097/00005053-199703000-00004

    Article CAS PubMed Google Scholar

  4. Cooper LA, Brown C, Vu HT, Palenchar DR, Gonzales JJ, Ford DE, Powe NR (2000) Primary care patients’ opinions regarding the importance of various aspects of care for depression. Gen Hosp Psychiatry 22(3):163–173. https://doi.org/10.1016/s0163-8343(00)00073-6

    Article CAS PubMed Google Scholar

  5. Givens JL, Datto CJ, Ruckdeschel K, Knott K, Zubritsky C, Oslin DW, Nyshadham S, Vanguri P, Barg FK (2006) Older patients’ aversion to antidepressants. A qualitative study. J Gen Int Med 21(2):146–151. https://doi.org/10.1111/j.1525-1497.2005.00296.x

    Article Google Scholar

  6. Angermeyer MC, Däumer R, Matschinger H (1993) Benefits and risks of psychotropic medication in the eyes of the general public: results of a survey in the Federal Republic of Germany. Pharmacopsychiatry 26(4):114–120. https://doi.org/10.1055/s-2007-1014354

    Article CAS PubMed Google Scholar

  7. McLeod JD, Pescosolido BA, Takeuchi DT, White TF (2004) Public attitudes toward the use of psychiatric medications for children. J Health Soc Behav 45(1):53–67. https://doi.org/10.1177/002214650404500104

    Article PubMed Google Scholar

  8. De Las Cuevas C, Peñate W (2015) Explaining pharmacophobia and pharmacophilia in psychiatric patients: relationship with treatment adherence. Hum Psychopharmacol 30(5):377–383. https://doi.org/10.1002/hup.2487

    Article Google Scholar

  9. Sajatovic M, Rosch DS, Sivec HJ, Sultana D, Smith DA, Alamir S, Buckley P, Bingham CR (2002) Insight into illness and attitudes toward medications among inpatients with schizophrenia. Psych Serv 53(10):1319–1321. https://doi.org/10.1176/appi.ps.53.10.1319

    Article Google Scholar

  10. Hoencamp E, Stevens A, Haffmans J (2002) Patients’ attitudes toward antidepressants. Psych Serv 53(9):1180–1181. https://doi.org/10.1176/appi.ps.53.9.1180-a

    Article Google Scholar

  11. Pogany L, Lazary J (2021) Health control beliefs and attitude toward treatment in psychiatric and non-psychiatric clinical samples. Front Psych 12:537309. https://doi.org/10.3389/fpsyt.2021.537309

    Article Google Scholar

  12. Lim M, Li Z, Xie H, Tan BL, Lee J (2021) The effect of therapeutic alliance on attitudes toward psychiatric medications in schizophrenia. J Clin Psychopharmacol 41(5):551–560. https://doi.org/10.1097/JCP.0000000000001449

    Article CAS PubMed Google Scholar

  13. Hogan TP, Awad AG, Eastwood R (1983) A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol Med 13(1):177–183. https://doi.org/10.1017/s0033291700050182

    Article CAS PubMed Google Scholar

  14. Hogan TP, Awad AG (1992) Subjective response to neuroleptics and outcome in schizophrenia: a re-examination comparing two measures. Psychol Med 22(2):347–352. https://doi.org/10.1017/s0033291700030282

    Article CAS PubMed Google Scholar

  15. Aydin E, Aydin E, Balaban ÖD, Yumrukçal H, Erkiran M (2018) The validity and reliability of the turkish version of drug attitude inventory-10. Noro psikiyatri arsivi 55(3):238–242. https://doi.org/10.5152/npa.2017.18078

    Article PubMed PubMed Central Google Scholar

  16. Horne R, Weinman J, Hankins M (1999) The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health 14(1):1–24

    Google Scholar

  17. Çınar M, Tekgöz E, Çınar Fİ, Yılmaz S (2018) Reliability and validity of the Turkish translation of the Beliefs about Medicines Questionnaire (BMQ-T) in patients with Behçet’s disease. Turkish Thoracic J 19(4):231. https://doi.org/10.5152/TurkThoracJ.2018.180108

    Article Google Scholar

  18. Czobor P, Van Dorn RA, Citrome L, Kahn RS, Fleischhacker WW, Volavka J (2015) Treatment adherence in schizophrenia: a patient-level meta-analysis of combined CATIE and EUFEST studies. Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol 25(8):1158–1166. https://doi.org/10.1016/j.euroneuro.2015.04.003

    Article CAS Google Scholar

  19. Eticha T, Teklu A, Ali D, Solomon G, Alemayehu A (2015) Factors associated with medication adherence among patients with schizophrenia in Mekelle, Northern Ethiopia. PloS one 10(3):e0120560. https://doi.org/10.1371/journal.pone.0120560

    Article CAS PubMed PubMed Central Google Scholar

  20. Velligan DI, Lam YW, Glahn DC, Barrett JA, Maples NJ, Ereshefsky L, Miller AL (2006) Defining and assessing adherence to oral antipsychotics: a review of the literature. Schizophr Bull 32(4):724–742. https://doi.org/10.1093/schbul/sbj075

    Article PubMed PubMed Central Google Scholar

  21. Grover S, Chakrabarti S, Sharma A, Tyagi S (2014) Attitudes toward psychotropic medications among patients with chronic psychiatric disorders and their family caregivers. J Neurosci Rural Pract 5(4):374–383. https://doi.org/10.4103/0976-3147.139989

    Article PubMed PubMed Central Google Scholar

  22. Grover S, Mehra A, Chakrabarti S, Avasthi A (2019) Attitude toward psychotropic medications: a comparison of the elderly and adult patients with affective and psychotic disorders. J Geriatric Mental Health 6(2):38–45

    Google Scholar

  23. Vrbová K, Kamarádová D, Látalová K, Ocisková M, Praško J, Mainerová B, Cinculová A, Kubínek R, Ticháčková A (2014) Self-stigma and adherence to medication in patients with psychotic disorders–cross-sectional study. Neuro Endocrinol Lett 35(7):645–652

    PubMed Google Scholar

  24. Saleem F, Hassali MA, Shafie AA, Awad AG, Bashir S (2011) Association between knowledge and drug adherence in patients with hypertension in Quetta. Pakistan. Trop J Pharm Res 10(2):125–132. https://doi.org/10.4314/tjpr.v10i2.66552

    Article Google Scholar

  25. Nebhinani N, Pareek V, Choudhary S, Tripathi S, Singh P, Kumar M (2022) Pathways of care and attitudes toward psychotropics in patients with depressive disorders and psychotic disorders. J Neurosci Rural Pract 13(4):785–790. https://doi.org/10.25259/JNRP-2021-11-39

    Article PubMed PubMed Central Google Scholar

  26. Chakrabarti S (2019) Treatment attitudes and adherence among patients with bipolar disorder: a systematic review of quantitative and qualitative studies. Harv Rev Psychiatry 27(5):290–302. https://doi.org/10.1097/HRP.0000000000000228

    Article PubMed Google Scholar

  27. Velligan DI, Sajatovic M, Hatch A, Kramata P, Docherty JP (2017) Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness. Patient Prefer Adherence 11:449–468. https://doi.org/10.2147/PPA.S124658

    Article PubMed PubMed Central Google Scholar

Download references

Acknowledgements

We are very grateful to all participants of our study for so generously taking the time to take part in our research.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

Contributions

Seda Yavuz: Conceptualization, Methodology, Formal analysis, Writing- Original draft preparation, Project administration, Writing—Review & Editing. Yavuz Yılmaz: Writing—Original draft preparation, Writing—Review & Editing, Project administration. Erdi Bahadır: Conceptualization, Review & Editing.

Corresponding author

Correspondence to Yavuz Yılmaz.

Ethics declarations

Conflicting interests

None.

Declaration of generative AI in scientific writing

During the preparation of this work the author(s) used ChatGPT 4-o in order to improve readability and language. After using this tool/service, the author(s) reviewed and edited the content as needed and take(s) full responsibility for the content of the publication.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Cite this article

Yavuz, S., Yılmaz, Y. & Bahadır, E. Understanding attitudes towards psychiatric medications: a comparative study of patients, healthcare professionals, and general population perspectives. Eur J Clin Pharmacol (2025). https://doi.org/10.1007/s00228-025-03879-7

Download citation

  • Received
  • Accepted
  • Published
  • DOIhttps://doi.org/10.1007/s00228-025-03879-7

Keywords

  • Attitudes
  • Psychiatric medications
  • Outpatients
  • Healthcare professionals
  • General population

 

WhatsApp